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Disodium sequestrene (Proescher, 1951 ; Hadley and Larson, 1953) and dipotassium sequestrene (Hadley and Weiss, 1955) are the most valuable of the recently introduced anticoagulants for routine haematological procedures because they preserve the morphology of leucocytes for short periods better than the ammonium and potassium oxalate mixture or heparin, and they prevent platelets clumping and preserve them. The disodium sequestrene is less satisfactory than the dipotassium salt because of its lower solubility in blood. Dilithium sequestrene was prepared and its properties as an anticoagulant were investigated. It was found to have the properties of dipotassium sequestrene in routine haematological work but could also be used in many biochemical procedures, including flame photometry. This salt had previously been investigated (Hadley and Weiss, 1955) In both cases the resulting solution contained the dilithium salt.
Dilithium sequestrene was obtained from these solutions after filtration to remove a small quantity of amorphous debris, by precipitation on the addition of an equal volume of absolute methyl alcohol and cooling. Dilithium sequestrene separated out as a fine white crystalline substance which was recovered by filtration on a buchner funnel and washed four times with 10 ml. of absolute methyl alcohol. The salt was dried at atmospheric pressure over anhydrous calcium chloride to a constant weight.
The usual yield by either of these methods was 29 g., namely, 85% of the theoretical yield. The most efficient method of distributing dilithium sequestrene was by placing the appropriate amount of a solution containing 2.1 g. per 100 ml. in 10% v/v methyl alcohol in water into each universal container. These containers were placed in a hot air oven at 1600 C. for 30 minutes. This procedure did not affect the anticoagulant properties of the salt or in any way lower its solubility in blood or cause its decomposition. All traces of methyl alcohol were also removed.
Physical Properties
The optimal amount of dilithium sequestrene for routine haematological and chemical estimations was found to be 0.2 ml. of this solution for 5 ml. of blood, i.e., 0.84 mg. per ml. The minimum amount to prevent coagulation is 0.52 mg. per ml.
The tolerance for haematological procedures, which ensures retention of good cell morphology, is between 1.05 mg. and 0.66 mg. per ml. of blood.
The tolerance for blood urea and electrolytes, except plasma chloride, is between the minimum amount necessary to prevent coagulation, i.e., 0.52 mg., and 4.2 mg. per ml. of blood.
For chlorides between 0.52 and 1.4 mg. per ml. is satisfactory.
Dipotassium and disodium sequestrene have been distributed into universal containers using the method previously described. The solubility of these salts in blood was as good as the solubility of dilithium salt under similar conditions.
Comparative chemical estimations were made on samples of the same blood taken into dilithium sequestrene and calcium heparin.
Comparative haematological investigations were made on samples of the same blood taken into dilithium sequestrene, dipotassium sequestrene, and the ammonium and potassium oxalate mixture.
Results Chemical Investigations.-The wavelength of the emission spectrum for lithium is 6708 A, for sodium 5890 A and 5896 A, and for potassium 7655 A. Using the EEL flame photometer with a coal gas/air flame no interference was detected due to lithium on the intensity of the sodium or potassium emission spectra, even when using 10 times the amount of lithium sequestrene normally present.
Sodium and potassium were estimated, using the flame photometer, on plasma from samples of blood anticoagulated with either calcium heparin or dilithium sequestrene. Plasma chloride was estimated by the method of Schales and Schales (1941) .
Blood urea was estimated by the method of Archer and Robb (1925) and plasma bicarbonate in the volumetric Van Slyke apparatus.
The electrolyte results obtained from 100 comparable samples of plasma are tabulated in Table I . Haematological Investigations.-In the investigation of dilithium sequestrene as an anticoagulant for haematological investigations a comparison was made between samples of the same blood taken into the ammonium and potassium oxalate mixture, which were estimated after contact with the anticoagulant for one hour, and dipotassium sequestrene and dilithium sequestrene, which were estimated after one and four hours' contact with the anticoagulant.
On each sample of blood taken in the ammonium and potassium oxalate mixture after one hour and each sample in dipotassium or L. S. SACKER AND OTHERS dilithium sequestrene after one and four hours the following investigations were performed:
(1) Haemoglobin using the oxyhaemoglobin method reading in a photo-electric colorimeter using an Ilford 625 filter, (2) blood sedimentation rate (Wintrobe method); (3) packed cell volume using an M.S.E. haematocrit centrifuge governed to 3,000 r.p.m. for 30 minutes; (4) platelet count using direct counting in blood diluted either 1 in 20 in Barr's fluid or 1 in 100 in formol citrate (Dacie, 1956 ); (5) total white cell count ; (6) blood films had differential white cell counts performed and were also examined for red cell morphology, platelet clumping and morphology, and the effect of the anticoagulants on leucocyte morphology.
Increased red cell destruction after contact with each of the three anticoagulants used was not found, as shown by spectroscopic examination of the supernatant plasma, plasma haemoglobin estimations, or the potassium level of separated plasma.
The results obtained by these methods on 50 different samples of blood are summarized.
(1) Haemoglobin Levels-The maximum difference between all the five haemoglobin estimations on one sample of blood was less than 10% in all specimens and less than 5% in 60% of the specimens.
(2) The Sedimentation Rate.-A Wintrobe technique blood sedimentation rate was performed on each sample of blood after one and four hours' contact with each of the three anticoagulants used.
Seventy-six per cent. of these groups of samples gave readings within 2% of each other when all three anticoagulants were compared at one and at four hours' contact.
The remaining 24% gave identical readings at one hour but showed marked and erratic increase of the sedimentation rate after four hours' contact with the anticoagulant.
(3) Packed Cell Volume.-Generally there was less than 1 % difference on any sample of the same specimen, but in eight specimens (16%) a constant reduction of 1 % was noted in those samples which had been in contact with the dipotassium or dilithium sequestrene, or ammonium and potassium oxalate anticoagulant for four hours when compared with a contact time of one hour. This is suggestive of a minor degree of red cell shrinkage due to the anticoagulant.
(4) Platelet Count.-Platelet counts on the blood taken in the ammonium and potassium oxalate mixture were unsatisfactory as in all samples platelets had clumped.
Platelet counts on sequestrene blood were satisfactory. All duplicate platelet counts varied within a range of + 10%, which is satisfactory.
It was noted occasionally that the platelets clumped in dilithium sequestrene if the anticoagulant had not been heated correctly at 1600 C.
for 30 minutes.
(5) White Cell Count.-The maximum variation noted in wet counts was well within 20% limits (Dacie, 1956) . (6 
Summary
The preparation and distribution of dilithium sequestrene, which may be used as a universal laboratory anticoagulant, are described.
